Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| CD4-positive, alpha-beta T cell | 3 studies | 62% ± 28% |
Insufficient scRNA-seq data for expression of EEF1A1P5 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| ovary | 100% | 3360.29 | 180 / 180 | 99% | 220.81 | 427 / 430 |
| esophagus | 99% | 1375.86 | 1426 / 1445 | 100% | 132.08 | 183 / 183 |
| thymus | 99% | 1782.99 | 645 / 653 | 96% | 121.00 | 578 / 605 |
| prostate | 99% | 1405.10 | 243 / 245 | 93% | 94.14 | 465 / 502 |
| lung | 100% | 1942.11 | 577 / 578 | 87% | 98.60 | 1004 / 1155 |
| stomach | 94% | 969.56 | 339 / 359 | 92% | 120.18 | 262 / 286 |
| breast | 100% | 1623.64 | 458 / 459 | 85% | 65.44 | 951 / 1118 |
| intestine | 99% | 1412.87 | 961 / 966 | 85% | 95.72 | 448 / 527 |
| kidney | 99% | 1629.12 | 88 / 89 | 79% | 77.12 | 710 / 901 |
| skin | 100% | 1756.90 | 1801 / 1809 | 75% | 62.32 | 356 / 472 |
| uterus | 100% | 1970.59 | 170 / 170 | 70% | 67.61 | 321 / 459 |
| bladder | 100% | 1200.10 | 21 / 21 | 63% | 45.75 | 316 / 504 |
| pancreas | 97% | 1323.54 | 317 / 328 | 63% | 37.52 | 112 / 178 |
| adrenal gland | 99% | 1125.66 | 255 / 258 | 60% | 36.83 | 139 / 230 |
| brain | 59% | 362.08 | 1566 / 2642 | 85% | 116.28 | 598 / 705 |
| blood vessel | 100% | 1381.24 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 100% | 1713.42 | 1203 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 98% | 852.46 | 236 / 241 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 97% | 111.39 | 28 / 29 |
| liver | 56% | 317.95 | 126 / 226 | 40% | 26.74 | 161 / 406 |
| eye | 0% | 0 | 0 / 0 | 81% | 101.19 | 65 / 80 |
| peripheral blood | 81% | 1655.68 | 748 / 929 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 67% | 45.48 | 30 / 45 |
| heart | 57% | 380.54 | 487 / 861 | 0% | 0 | 0 / 0 |
| muscle | 23% | 168.22 | 186 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0006412 | Biological process | translation |
| GO_0006414 | Biological process | translational elongation |
| GO_0008150 | Biological process | biological_process |
| GO_0005615 | Cellular component | extracellular space |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0005525 | Molecular function | GTP binding |
| GO_0003746 | Molecular function | translation elongation factor activity |
| GO_0003674 | Molecular function | molecular_function |
| GO_0003924 | Molecular function | GTPase activity |
| Gene name | EEF1A1P5 |
| Protein name | Putative elongation factor 1-alpha-like 3 (EF-1-alpha-like 3) (Eukaryotic elongation factor 1 A-like 3) (eEF1A-like 3) (Eukaryotic translation elongation factor 1 alpha-1 pseudogene 5) |
| Synonyms | EEF1AL3 |
| Description | FUNCTION: This protein promotes the GTP-dependent binding of aminoacyl-tRNA to the A-site of ribosomes during protein biosynthesis. . |
| Accessions | Q5VTE0 |